These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2939997)

  • 21. Evaluation of diversified antigens for detection of Mycobacterium leprae antibodies from leprosy patients and contacts.
    Singh NB; Bhatnagar S; Choudhary A; Gupta HP; Kaul SM
    Indian J Exp Biol; 1994 Jul; 32(7):478-81. PubMed ID: 7959924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clarification to Rada-Schlaefli, et al.
    Iyer A; Mistry N; Antia N; Harboe M
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):63-4. PubMed ID: 10834071
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunodiagnostic tests for leprosy; a need for standards.
    Ramanathan VD
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):721-2. PubMed ID: 3323373
    [No Abstract]   [Full Text] [Related]  

  • 24. [Preliminary study on the serological activity of phenolic glycolipid and its application to leprosy].
    Wu QX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Feb; 8(1):46-50. PubMed ID: 2943444
    [No Abstract]   [Full Text] [Related]  

  • 25. Serological activity of natural disaccharide octyl bovine serum albumin (ND-O-BSA) in sera from patients with leprosy, tuberculosis, and normal controls.
    Wu QX; Ye GY; Li XY
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):50-5. PubMed ID: 3131466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to a synthetic analog of phenolic glycolipid-I of Mycobacterium leprae in healthy household contacts of patients with leprosy.
    Menzel S; Harboe M; Bergsvik H; Brennan PJ
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):617-25. PubMed ID: 3323365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to mycobacterial arabinomannan in leprosy: correlation with reactional states and variation during treatment.
    Miller RA; Harnisch JP; Buchanan TM
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):133-9. PubMed ID: 6373624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of non-conventional antigen: M. habana in detecting M. leprae antibodies from leprosy patients and contacts in FLA-ABS test.
    Rana NS; Gupta HP; Singh NB
    Indian J Lepr; 1988 Oct; 60(4):593-9. PubMed ID: 3075637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of antibodies to phenolic glycolipid by ELISA in leprosy patients.
    Lal H; Jain VK; Mittal RA; Chaudhary SD; Saini V
    Indian J Lepr; 1993; 65(1):95-9. PubMed ID: 8463728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of recombinant ESAT-6 antigen (ML0049) for detection of leprosy patients.
    Parkash O; Pandey R; Kumar A; Kumar A
    Lett Appl Microbiol; 2007 May; 44(5):524-30. PubMed ID: 17451520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
    Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative and combinatorial study on two serological assays for detection of Mycobacterium leprae infection.
    Parkash O; Girdhar BK
    Acta Leprol; 2001-2002; 12(2):63-9. PubMed ID: 12136738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recognition of Mycobacterium leprae recombinant 18,000 MW epitopes by IgG subclasses in leprosy.
    Hussain R; Menz B; Dockrell HM; Chiang TJ
    Immunology; 1995 Feb; 84(2):290-7. PubMed ID: 7538491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A strategy to improve the ml flow test for detection of anti-phenolic glycolipid-1 antibodies.
    Parkash O
    Lepr Rev; 2004 Jun; 75(2):192-3; author reply 194-5. PubMed ID: 15282973
    [No Abstract]   [Full Text] [Related]  

  • 35. [Ultramicro ELISA to the detection of IgM antibodies in Mycobacterium leprae using dry blood samples].
    Torrella A; Solis RL; Rodriguez N; Medina Y; Pita M; Perez I; Licourt N
    Rev Inst Med Trop Sao Paulo; 1994; 36(2):131-8. PubMed ID: 7997788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Class-specific immunoglobulins and antibodies to mycobacterial sonicates and autoantigens in leprosy patients and contacts.
    Mathew JM; Muthukkaruppan V
    Microb Pathog; 1993 Nov; 15(5):367-76. PubMed ID: 8015417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of anti-M. leprae phenolic glycolipid-I antibody detection for early diagnosis and prognosis of leprosy.
    Agis F; Schlich P; Cartel JL; Guidi C; Bach MA
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):527-35. PubMed ID: 3065419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ELISA detection of IgM antibodies against phenolic glycolipid-I in the management of leprosy: a comparison between laboratories.
    Meeker HC; Levis WR; Sersen E; Schuller-Levis G; Brennan PJ; Buchanan TM
    Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):530-9. PubMed ID: 3546543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to phenolic glycolipid-I during long-term therapy: serial measurements in individual patients.
    Miller RA; Gorder D; Harnisch JP
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):633-6. PubMed ID: 3323367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of major membrane protein-II as a tool for serodiagnosis of leprosy.
    Maeda Y; Mukai T; Kai M; Fukutomi Y; Nomaguchi H; Abe C; Kobayashi K; Kitada S; Maekura R; Yano I; Ishii N; Mori T; Makino M
    FEMS Microbiol Lett; 2007 Jul; 272(2):202-5. PubMed ID: 17521364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.